Life Science Matters An inside look at the latest legal developments involving medical devices, pharmaceuticals, and more

  • Home
  • About
  • Categories
    • ANDA
    • Class Action
    • Coronavirus
    • Daubert
    • Design Defect
    • FDA
    • IP
    • Labeling
    • Medical Device
    • News
    • Nutritional Supplements
    • Off Label
    • Pharmacy
    • Pharmaceuticals
    • Preemption
    • Recalls
    • Regulatory
    • Sales Representatives
    • Settlements
    • Supplements
    • Verdicts
  • Resources
  • Subscribe
  • Contact Us

This Week’s Life Science Headlines

  • December 1, 2013
  • /
  • Design Defect FDA Litigation Medical Device News Nutritional Supplements Pharmaceuticals Product Liability Recalls Regulatory Settlements
  • /
  • Life Science Matters
        Litigation
  • Stryker Rejuvenate Lawsuits Filed by Nearly 1,000 Hip Patients Nationwide
  • Novartis Can’t Apply NJ Punitives Cap in 3 Zometa Suits (subscription required)
  • Pfizer Escapes FCA Suit Over Anti-Fungal Drug Promotions (subscription required)
  • Gardasil Lawsuit Filed in France Over Side Effects of HPV Vaccine 
  • Judge Backs Jury Finding in J&J Body Powder Cancer Suit (subscription required) 
  • OxyElite Pro Class Action Filed Over False Advertising 
  • First Zoloft Trial in Federal MDL for Birth Defect Lawsuits to Begin Nov. 2014 
  • J&J Takes Innovative,
…
Continue reading...
  • Abbott Amgen Amgen anemia claims Anti-funal drug promotion Avandia avandia REMS program Body Powder Cancer Suit DNA testing FDA Gardasil GlaxoSmithKline GSK hip implant lawsuits J&J Johnson & Johnson Novartis Oxy Elite false advertising OxyElite OxyELITE Pro Pfizer recall of FreeStyle recall of FreeStyle Lite Side Effect of HPV Vaccine stryker Stryker Rejuvenate Stryker rejuvenate lawsuits unapproved research tests Viscocel recall zoloft zoloft birth defects zoloft mdl zoloft trial Zometa Zometa lawsuits
Goldberg Segalla

Search

Categories

  • Posts
  • Multicounty Litigation Order in New Jersey Provides No Guidance to Practitioners June 23, 2021
  • New Multicounty Litigation Application in New Jersey June 8, 2021
  • Lack of Agreement to Arbitrate Dooms Bid to Compel Arbitration May 26, 2021
  • Mixed Bag in New Jersey Medical Device Preemption Opinion May 12, 2021
  • First Circuit Agrees Pharmacists Provide Services, Not Sell Goods April 27, 2021

About Us

Goldberg Segalla is a national civil litigation firm with more than 20 offices in 10 states spanning major metro markets across the U.S., providing strategic coverage wherever our clients do business. As a firm of experienced litigators and trial attorneys, our capabilities span business and commercial disputes, employment and labor, insurance coverage, product liability, and more. Today, our nearly 400 attorneys are trusted counselors to public and private clients in key sectors and industries including construction and energy, transportation, manufacturing, retail and hospitality, and insurance.

Links

  • Home
  • About
  • Resources
  • Contact Us
Copyright 2023 · Goldberg Segalla